Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Efficacy and Safety APT-1011 in Adult Subjects With Eosinophilic Esophagitis (EoE) (FLUTE-2)

ClinicalTrials.gov ID: NCT04281108

Public ClinicalTrials.gov record NCT04281108. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 27, 2026, 3:07 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Fluticasone Propionate Oral Dispersible Tablet Formulation in Eosinophilic Esophagitis: A Two-Part, Randomized, Double-blind, Placebo-Controlled Study of APT-1011 With an Open-label Extension, in Adult Subjects With Eosinophilic Esophagitis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a 2-part randomized, double-blind, placebo-controlled study followed by an open-label extension (OLE) of APT-1011 in adults with EoE. Part A will evaluate the efficacy and safety of APT-1011 3 mg administered hora somni (HS; at bedtime) for the induction of response to treatment (histologic and symptomatic) over 12 weeks. Part B will evaluate histological relapse-free status in patients re-randomized to continue APT-1011 or placebo (active treatment withdrawal) until Week 52. Part C, the OLE, will continue until regulatory approval of APT-1011 or Sponsor termination of the study.

Study identification

NCT ID
NCT04281108
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Ellodi Pharmaceuticals, LP
Industry
Enrollment
143 participants

Conditions and interventions

Interventions

Drug · Procedure

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 30, 2020 (Actual)
Primary completion
May 5, 2022 (Actual)
Completion
Oct 24, 2022 (Actual)
Last update posted
Jun 12, 2023

2020 – 2022

United States locations

U.S. sites
48
U.S. states
23
U.S. cities
46
Facility City State ZIP Site status
Pinnacle Research Group, LLC Anniston Alabama 36207 —
Gut P.C., dba; Digestive Health Specialists of the Southeast Dothan Alabama 36305 —
East View Medical Research, LLC Mobile Alabama 36606 —
Del Sol Research Management, LLC Tucson Arizona 85712 —
Preferred Research Partners Inc. Little Rock Arkansas 72211 —
Arkansas Gastroenterology North Little Rock Arkansas 72117 —
Camarillo Endoscopy Center Camarillo California 93012 —
Hope Clinical Research Canoga Park California 91303 —
Facey Medical Foundation Mission Hills California 91345 —
United Medical Doctors Murrieta California 92563 —
Medical Associates Research Group San Diego California 92123 —
Asthma and Allergy Associates, PC Colorado Springs Colorado 80907 —
Peak Gastroenterology Associates Colorado Springs Colorado 80907 —
Western States Clinical Research Inc. Wheat Ridge Colorado 80033 —
Western Connecticut Medical Group - Gastroenterology Danbury Connecticut 06810 —
Medical Research Center of Connecticut, LLC Hamden Connecticut 06518 —
Fleming Island Center for Clinical Research Fleming Island Florida 32003 —
Nature Coast Clinical Research Inverness Florida 34452 —
Encore Borland Groover Clinical Research Jacksonville Florida 32256 —
Endoscopic Research, Inc. Orlando Florida 32803 —
DBC Research USA Pembroke Pines Florida 33029 —
Summit Clinical Research Athens Georgia 30607 —
University of Iowa Hospitals and Clinics Iowa City Iowa 52242 —
MGG Group Co., Inc., Chevy Chase Clinical Research Chevy Chase Maryland 20815 —
Gastro Center of Maryland Columbia Maryland 21045 —
Michigan Medicine, University of Michigan Ann Arbor Michigan 48109 —
Clinical Research Institute of Michigan LLC Chesterfield Michigan 48047 —
Henry Ford Health System Novi Michigan 48377 —
West Michigan Clinical Research Center Wyoming Michigan 49519 —
Minnesota Gastroenterology, P.A. Plymouth Minnesota 55446 —
Mayo Clinic Rochester Minnesota 55905 —
Clinical Research Professionals Chesterfield Missouri 63005 —
Bozeman Health GI Clinic Bozeman Montana 59715 —
Long Island Gastrointestinal Research Group LLP Great Neck New York 11023 —
University of North Carolina Health Systems (UNC Hospital) Chapel Hill North Carolina 27599 —
Carolina Research Greenville North Carolina 27834 —
Consultants for Clinical Research Cincinnati Ohio 45219 —
Bernstein Clinical Research Center, LLC Cincinnati Ohio 45231 —
Great Lakes Gastroenterology Research, LLC Mentor Ohio 44060 —
Northshore Gastroenterology Research, LLC Westlake Ohio 44145 —
Vital Prospects Clinical Research Institute, P.C. Tulsa Oklahoma 74136 —
Perelman Center for Advanced Medicine Philadelphia Pennsylvania 19104 —
Digestive Disease Associates LTD Wyomissing Pennsylvania 19610 —
Rapid City Medical Center LLP Rapid City South Dakota 57701 —
DHAT Research Institute Garland Texas 75044 —
Advanced Research Institute Ogden Utah 84405 —
Verity Research, Inc. Fairfax Virginia 22031 —
Blue Ridge Medical Research Lynchburg Virginia 24502 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 8 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04281108, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 12, 2023 · Synced Oct 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04281108 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →